tirzepatide vs semaglutide weight loss timeline Tirzepatide: Which GLP-1 Wins for Loss? Tirzepatide vs. Semaglutide: What's the
Description
There were 93 patients (0.12%) with other optic nerve disorders in the semaglutide or tirzepatide group and 54 patients (0.07%) with other optic nerve disorders in the matched comparison group (hazard ratio, 1.65 [95% CI, 1.18-2.31])
If you experience unexpected diminished appetite suppression, temperature-related degradation should be ruled out before adjusting your dose

Skin cells are very susceptible to telomere shortening and oxidative stress
Frequent blood glucose monitoring and proactive insulin dose adjustment are essential

Supplements to consider GLP-1 medications can affect nutrient absorption, making targeted supplementation important for some patients

then mL 100 = units on a U-100 insulin syringe
